Associated Papers
ANXA11 Mutations in the FTD Spectrum: A Novel Finding in a Patient With Semantic Variant Primary Progressive Aphasia.
Meng Y et al.
European Journal of Neurology, 2025
Clinical characteristics of semantic variant of primary progressive aphasia with TDP-43- and tau-related gene variants.
Ma Y et al.
Journal of Alzheimer's Disease : Jad, 2025
Cellular and pathological functions of tau.
Parra Bravo C et al.
Nature Reviews. Molecular Cell Biology, 2024
Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation.
Sun KT et al.
Acs Chemical Neuroscience, 2023
Diagnostic criteria in dementing illness. What's new?
Labos E et al.
Vertex (buenos Aires, Argentina), 2023
In vitro Tau Aggregation Inducer Molecules Influence the Effects of MAPT Mutations on Aggregation Dynamics.
Ingham DJ et al.
Biochemistry, 2022
Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey.
da Costa PJ et al.
Biomedicines, 2022
Tau Protein and Frontotemporal Dementias.
Goedert M et al.
Advances in Experimental Medicine and Biology, 2021
Foix-Chavany-Marie syndrome due to type E TDP43 pathology.
Clark CN et al.
Neuropathology and Applied Neurobiology, 2020
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
Moore KM et al.
The Lancet. Neurology, 2020
MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Strang KH et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2019
The RNA encoding the microtubule-associated protein tau has extensive structure that affects its biology.
Chen JL et al.
Plos One, 2019
Ordered Assembly of Tau Protein and Neurodegeneration.
Goedert M et al.
Advances in Experimental Medicine and Biology, 2019
Different tau species lead to heterogeneous tau pathology propagation and misfolding.
Dujardin S et al.
Acta Neuropathologica Communications, 2018
Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH et al.
The Journal of Biological Chemistry, 2018
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL et al.
Brain : a Journal of Neurology, 2018
Therapeutic Strategies for Restoring Tau Homeostasis.
Young ZT et al.
Cold Spring Harbor Perspectives in Medicine, 2018
Genetics of Progressive Supranuclear Palsy.
Im SY et al.
Journal of Movement Disorders, 2015
NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
Goedert M
Science (new York, N.y.), 2015
Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.
Ghetti B et al.
Neuropathology and Applied Neurobiology, 2015
Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia.
Flanagan EP et al.
Dementia and Geriatric Cognitive Disorders, 2015
Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations.
Rossi G et al.
Frontiers in Aging Neuroscience, 2015
Regulation of alternative splicing of tau exon 10.
Qian W et al.
Neuroscience Bulletin, 2014
Frontotemporal dementia: implications for understanding Alzheimer disease.
Goedert M et al.
Cold Spring Harbor Perspectives in Medicine, 2012
Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S.
Deramecourt V et al.
Journal of Alzheimer's Disease : Jad, 2012